The Center for Diabetes Technology seeks women ages 18 to 40 with Type 1 Diabetes for a research study. The purpose of the study is find out how much the menstrual cycle effects the blood glucose variability and the effectiveness of insulin delivery. You may be eligible for this study if you are a woman who has had type 1 diabetes for at least 1 year, have used an insulin pump for at least 6 months, your A1c is under 8.5% (tested within 6 months), and have used a Continuous Glucose Monitor (CGM) in the last 6 months.
Your participation in this study will last about 3 months and involve about 5 visits. The first visit is a screening visit to determine the safety of your participation and includes a review of your medical history, a urine pregnancy test, and a physical exam. After the screening visit, you will be trained on the study equipment which includes a CGM and Activity Tracker. You will also be asked to track information about your cycle into an App, the amount of carbohydrate you consume each day, download your data on a regular basis and, if not using an oral contraceptive, perform ovulation tests. You will have check-in visits with study staff at least once a month. The final visit includes return of study equipment, a urine pregnancy test and a fingerstick A1c test. Study visits may be completed in person or completed virtually.
Study-related supplies, exams, and A1c testing (if needed) provided free of charge.
Compensation is provided.